Draupnir Bio
Draupnir Bio is developing a new type of cholesterol-lowering medicine which prevents blood clots in the heart.
Business Model:
Revenue: $0
Employees: 10,001-1
Rankings
Industries / Tags:
Detailed Draupnir Bio Information
Geographic Data
Address: C/O BioInnovation Institute Ole Maaløes Vej 3
City: Copenhagen
State: zealand
Zip: DK-2200
Country: DK
Financial Info
Stage:
series unknown
Raised Last:
$33M
Raised Total:$33M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Draupnir Bio intends to develop a new type of cholesterol-lowering medicine that prevents blood clots in the heart more effectively than the current medicine. The company is developing a platform for exploring the glycome to develop novel therapeutics, based on array technology, protein chemistry, and advanced carbohydrate chemistry. The company is able to synthesize, screen, and select highly potent and specific heparan sulfate glycomimetic drug candidates in cardiovascular, inflammatory, and infectious diseases.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2019 | Venture Round | 4 | $33M |
Gilde Healthcare High-Tech Grunderfonds Inkef Novo Holdings Gilde Healthcare High-Tech Grunderfonds Inkef Novo Holdings |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
